ORMP
NASDAQ · Pharmaceuticals
Oramed Pharmaceuticals Inc
$3.95
-0.03 (-0.75%)
Open$3.98
Previous Close$3.98
Day High$4.02
Day Low$3.91
52W High$4.22
52W Low$1.98
Volume—
Avg Volume158.0K
Market Cap160.37M
P/E Ratio2.50
EPS$1.50
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+141.8% upside
Current
$3.95
$3.95
Target
$9.55
$9.55
$5.95
$9.55 avg
$10.69
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.91M | 2.11M | 32.28M |
| Net Income | 61.30M | 60.98M | 5.51M |
| Profit Margin | 3,202.5% | 3,042.4% | 17.1% |
| EBITDA | -14,230,220 | -14,941,101 | 8.62M |
| Free Cash Flow | — | — | 3.23M |
| Rev Growth | -9.5% | -9.5% | +15.3% |
| Debt/Equity | — | — | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |